Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Nov 17, 2015
0
996